The University of Chicago Header Logo


Alexander Pearson to Receptor, Fibroblast Growth Factor, Type 1

This is a "connection" page, showing publications Alexander Pearson has written about Receptor, Fibroblast Growth Factor, Type 1.
  1. Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study. Clin Cancer Res. 2020 01 15; 26(2):354-363.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.